Nevada
Provider Communications
New specialty pharmacy medical step therapy requirements
The clinical criteria below will be updated to include the requirement of a preferred agent effective
January 1, 2021.
Clinical criteria |
Preferred drug |
Nonpreferred drug |
ING-CC-0167 |
Ruxience (Q5119) Truxima (Q5115) |
Rituxan (J9312) |
The clinical criteria is publicly available on our provider website.
What if I need assistance?
If you have questions about this communication or need assistance with any other item, contact your local Provider Relations representative or call Provider Services at 1-844-396-2330.
Featured In:
March 2021 Anthem Provider News and Important Updates -- Nevada